This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1976 Mar;56(3):371P.

Proceedings: CF 25-397 (9, 10-didehydro-6-methyl-8beta-(2-pyridylthiomethyl) ergoline), a new central dopamine receptor agonist

A L Jaton, D M Loew, J M Vigouret

PMID: 944059
PMCID: PMC1666968

Proceedings: CF 25-397 (9, 10-didehydro-6-methyl-8beta-(2-pyridylthiomethyl) ergoline), a new central dopamine receptor agonist

A L Jaton et al. Br J Pharmacol. 1976 Mar.

. 1976 Mar;56(3):371P.

Authors

A L Jaton, D M Loew, J M Vigouret

PMID: 944059
PMCID: PMC1666968

No abstract available

PubMed Disclaimer

Similar articles

The brain's dopamine receptor: labeling with (3H) dopamine and (3H) haloperidol.
Snyder SH, Creese I, Burt DR. Snyder SH, et al. Psychopharmacol Commun. 1975;1(6):663-73. Psychopharmacol Commun. 1975. PMID: 1241457 No abstract available.
The 6-hydroxydopamine rotational model for the detection of dopamine agonist activity: reliability of effect from different locations of 6-hydroxydopamine.
Costall B, Naylor RJ, Pycock C. Costall B, et al. J Pharm Pharmacol. 1975 Dec;27(12):943-6. doi: 10.1111/j.2042-7158.1975.tb10253.x. J Pharm Pharmacol. 1975. PMID: 2668 No abstract available.
Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
Johnson AM, Loew DM, Vigouret JM. Johnson AM, et al. Br J Pharmacol. 1976 Jan;56(1):59-68. doi: 10.1111/j.1476-5381.1976.tb06959.x. Br J Pharmacol. 1976. PMID: 943193 Free PMC article.
6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome.
Ungerstedt U. Ungerstedt U. Pharmacol Ther B. 1976;2(1):37-40. doi: 10.1016/0306-039x(76)90016-7. Pharmacol Ther B. 1976. PMID: 772721 Review. No abstract available.
Antiparkinsonian drugs and dopaminergic neostriatal mechanisms: studies in rats with unilateral 6-hydroxydopamine (=6-OH-DA)-induced degeneration of the nigro-neostriatal DA pathway and quantitative recording of rotational behaviour.
Fuxe K, Ungerstedt U. Fuxe K, et al. Pharmacol Ther B. 1976;2(1):41-7. doi: 10.1016/0306-039x(76)90017-9. Pharmacol Ther B. 1976. PMID: 817332 Review. No abstract available.

See all similar articles

Cited by

Turning behaviour elicited by apomorphine, (+)-amphetamine and three ergot derivatives in rats treated with a unilateral injection of ethanolamine-O-sulphate in the substantia nigra [proceedings].
Jaton AL, Loew DM, Vigouret JM. Jaton AL, et al. Br J Pharmacol. 1977 Mar;59(3):464P-465P. Br J Pharmacol. 1977. PMID: 843708 Free PMC article. No abstract available.
Dopamine agonists and cobalt-induced epilepsy in the rat.
Farjo IB, McQueen JK. Farjo IB, et al. Br J Pharmacol. 1979 Nov;67(3):353-60. doi: 10.1111/j.1476-5381.1979.tb08687.x. Br J Pharmacol. 1979. PMID: 497536 Free PMC article.
Treatment of Schizophrenia with ergot derivatives.
Tamminga CA, Schaffer MH. Tamminga CA, et al. Psychopharmacology (Berl). 1979;66(3):239-42. doi: 10.1007/BF00428312. Psychopharmacology (Berl). 1979. PMID: 119270 Clinical Trial.
Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF25--397, and 29--712: effects on the metabolism of the biogenic amines in the brain of the rat.
Bürki HR, Asper H, Ruch W, Züger PE. Bürki HR, et al. Psychopharmacology (Berl). 1978 May 31;57(3):227-37. doi: 10.1007/BF00426743. Psychopharmacology (Berl). 1978. PMID: 97702 No abstract available.

References

1. Eur J Pharmacol. 1972 Apr;18(1):83-94 - PubMed
1. Brain Res. 1970 Dec 18;24(3):485-93 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources